INTRODUCTION ABOUT JALRA TRIO FORTE TABLET

JALRA TRIO FORTE TABLET is a combination of Dapagliflozin, metformin, and vildagliptin, which belongs to a group of medicines called Antidiabetic agents. It is used as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus (T2DM). Along with management, follow a regular exercise and diet plan as advised by the doctor to achieve better results.

Dapagliflozin increases urinary glucose excretion and reduces blood glucose levels. Metformin works to control blood sugar by helping insulin, naturally produced by your body, decrease the amount of sugar your liver makes and also decrease the amount of sugar your intestines absorb. Vildagliptin is a potent and selective dipeptidylpeptidase-4 (DPP-4) inhibitor that improves glycemic control. Vildagliptin inhibition of DPP-4 results in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide).

JALRA TRIO FORTE TABLET is not recommended if you have type 1 diabetes, diabetic ketoacidosis, acute or chronic metabolic acidosis, a history of lactic acidosis, or severe dehydration. Before taking it, inform your doctor if you are scheduled for surgery, x-ray or scanning procedures, or vitamin B12 or folic acid deficiency. JALRA TRIO FORTE TABLET is not recommended for pregnant and breastfeeding women. The safety and effectiveness of JALRA TRIO FORTE TABLET in children and adolescents have not been established.

When taking JALRA TRIO FORTE TABLET, alcohol consumption is not recommended. The most common side effects of taking JALRA TRIO FORTE TABLET are low sugar levels, painful urination, repetitive urination, inflammation of the penis (in men), and allergic reactions. Contact your doctor if any of the above side effects worsen or persist for a longer duration.

USES OF JALRA TRIO FORTE TABLET

• It is used as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus (T2DM).

HOW JALRA TRIO FORTE TABLET WORKS

JALRA TRIO FORTE TABLET is a combination of dapagliflozin, metformin, and vildagliptin, which helps to lower blood glucose levels. Dapagliflozin works by inhibiting the reabsorption of glucose in the kidneys, causing excess glucose to be excreted through urine. By lowering blood glucose levels, dapagliflozin helps to improve glycemic control in patients with type 2 diabetes. Metformin works to control blood sugar by helping insulin, naturally produced by your body, decrease the amount of sugar your liver makes and also decrease the amount of sugar your intestines absorb. Vildagliptin is a potent and selective dipeptidylpeptidase-4 (DPP-4) inhibitor that improves glycemic control. Vildagliptin inhibition of DPP-4 results in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide).

DIRECTIONS FOR USE

Take JALRA TRIO FORTE TABLET as advised by your physician. Swallow JALRA TRIO FORTE TABLET with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending on your age, body weight, and disease condition. Do not stop taking JALRA TRIO FORTE TABLET without informing your doctor.

SIDE EFFECTS OF JALRA TRIO FORTE TABLET

HOW TO MANAGE SIDE EFFECTS

WARNING & PRECAUTIONS

INTERACTIONS

A. Drug-Drug interactions:

Before taking JALRA TRIO FORTE TABLET, inform your doctor if you are taking any of the following medicines:

• Other diabetic medications (Ex. glyburide, insulin, and rosiglitazone)
• Water pills (diuretics) (Ex. furosemide)
• Birth control pills (Ex. ethinyl estradiol)
• Sympathomimetics (Ex. xylometazoline)
• Thyroid medicines (Ex, levothyroxine)
• Corticosteroids (Ex. prednisone)
• Anti-epileptic (Ex. phenytoin)
• Anti-lipemic (Ex. nicotinic acid)
• Anti-tubercular (Ex. isoniazid)
• Cardiovascular agents (Ex. nifedipine, digoxin, procainamide, quinidine, amiloride, and triamterene)
• Antimalarial (Ex. quinine)
• Anti-ulcers (Ex. cimetidine, ranitidine)
• Opioid analgesics (Ex. morphine)
• Antibiotics (Ex. trimethoprim, vancomycin)
• Blood thinners (Ex. warfarin)

Overdosage:

If you or anyone else takes too much of JALRA TRIO FORTE TABLET, contact your doctor immediately or go to the nearest hospital right away. Symptoms of an overdose are muscle pain, mild and transient paraesthesia, fever, edema, and hypoglycemia.

SYNOPSIS

MORE INFORMATION